Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and ...
Allosteric Bioscience, Inc. is delineating the Molecular Mechanism of Aging and Longevity with the goal of optimizing the aging process and extending longevity. It is utilizing Genomics, Biology, ...
The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine continue to reshape how diseases are detected and managed. Within this ...
Xanadu Quantum Technologies Inc. ("Xanadu"), a leading photonic quantum computing company, today is hosting its 2026 Analyst Day at the Nasdaq MarketSite in New York, in advance of the anticipated ...
Infleqtion has been selected to advance to Phase 3 of the Q4Bio Challenge, a global program demonstrating quantum-enabled solutions for human health.
Zacks.com on MSN
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
NeoGenomics, Inc. NEO recently announced the availability of its new pan-solid tumor assay, PanTracer Pro, designed to help clinicians navigate increasingly complex molecular testing workflows to make ...
The Trump administration's campaign to end “wokeness” in the military is reshaping its relationship with U.S. higher ...
4don MSN
Mobile World Congress 2026: From robot phones to Europe's 5G warning it may be 'out of the game'
GSMA's director general, Vivek Badrinath, spoke to Euronews about what to expect from the technology conference and issued a ...
As Brussels negotiates its next long-term budget, chief prosecutor Laura Kövesi warned that nearly 1,000 ongoing VAT and ...
Nobel chemistry laureate Frances Arnold: ‘Whole swaths of science are just going to die on the vine’
The Caltech professor on using AI to harness the power of enzymes — and what US funding cuts could mean for research ...
The Global 2D Materials Market is projected to grow at a CAGR of 15.8% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was valued ...
Q4 2025 Earnings Call March 3, 2026 3:30 AM ESTCompany ParticipantsJames Peter Wroath - CEO & Executive DirectorDavid Burke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results